Innovative Approaches in Pediatric Drug Formulation Catering to Specialised Need


Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 03 | Issue : 01 | Page : –
    By

    Mohd. Wasiullah,

  • Piyush Yadav,

  • Satish Kumar Yadav,

  • Ratnesh Yadav,

  1. Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  2. Academic Head, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Associate Professor, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  4. Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_161298’);});Edit Abstract & Keyword

This Detailed Article Review Examines Innovations In Pediatric Drug Formulation, Highlighting Developments That Cater To Children’s Specific Healthcare Needs. It Covers Pediatric Pharmacology And Advanced Solutions Like Nanoparticle Drug Delivery And Taste-Masking Techniques, Focusing On Improving The Safety, Effectiveness, And Acceptability Of Medications For Young Patients. The review highlights the benefits for patients, including improved adherence to treatment, fewer side effects, and better overall treatment outcomes. It Also Addresses Regulatory And Ethical Issues, Emphasizing The Need For A Careful Balance Between Scientific Advancements And Ethical Responsibilities. The Conclusion Envisions A Future With Precision Medicine And Personalized Formulations While Recognizing The Challenges Ahead For Pediatric Healthcare. It Includes Novel Dosage Forms Designed For Children, Like Oral Liquids, Orally Disintegrating Tablets, And Chewable Options, As Well As Advancements In Taste-Masking Technologies To Improve Medication Palatability. The Review Also Emphasizes Age-Appropriate Dosing, Personalized Medicine Strategies, And User-Friendly Administration Devices.

Keywords: Drug Formulation, Pediatric Pharmacology, Nanoparticles, Patient Compliance, , Regulatory Compliance

[This article belongs to International Journal of Biochemistry and Biomolecule Research (ijbbr)]

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Satish Kumar Yadav, Ratnesh Yadav. Innovative Approaches in Pediatric Drug Formulation Catering to Specialised Need. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):-.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Satish Kumar Yadav, Ratnesh Yadav. Innovative Approaches in Pediatric Drug Formulation Catering to Specialised Need. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):-. Available from: https://journals.stmjournals.com/ijbbr/article=2025/view=0


document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_161298’);});Edit

References

  1. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: From neonates to adolescents. Adv Drug Deliv Rev. 2006 Apr 20;58(1):4-14. Doi: 10.1016/j.addr.2005.12.001.
  2. Green DJ, Zineh I, Burckart GJ. Pediatric drug development: outlook for science‐based innovation. Clinical Pharmacology & Therapeutics. 2018 Mar;103(3):376-8.
  3. Smyth RL, Edwards AD. A major new initiative to improve treatment for children. Archives of disease in childhood. 2006 Mar 1;91(3):212-3.
  4. Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. Journal of pharmaceutical sciences. 2013 Sep 1;102(9):2941-52.
  5. Bartelink IH, Rademaker CM, Schobben AF, Van Den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clinical pharmacokinetics. 2006 Nov;45:1077-97.
  6. Cohen-Wolkowiez M, Moran C, Benjamin Jr DK, Smith PB. Pediatric antifungal agents. Current opinion in infectious diseases. 2009 Dec 1;22(6):553-8.
  7. Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. The Journal of Pediatric Pharmacology and Therapeutics. 2014 Oct 1;19(4):262-76.
  8. Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, Van Weissenbruch MM. Clinical pharmacokinetics of phenobarbital in neonates. European journal of pharmaceutical sciences. 2000 Dec 1;12(2):111-6.
  9. Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert opinion on drug delivery. 2007 Jan 1;4(1):37-45.
  10. Alcorn J, mcnamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants part I. Clinical pharmacokinetics. 2002 Oct;41:959-98.
  11. Silverio J, Poole JW. Serum concentrations of ampicillin in newborn infants after oral administration. Pediatrics. 1973 Mar 1;51(3):578-80.
  12. Bodé S, Dreyer M, Greisen G. Gastric emptying and small intestinal transit time in preterm infants: a scintigraphic method. Journal of pediatric gastroenterology and nutrition. 2004 Oct 1;39(4):378-82.
  13. Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children. Fundamental & clinical pharmacology. 2003 Jun;17(3):281-99.
  14. Rakhmanina NY, van den Anker JN. Pharmacological research in pediatrics: from neonates to adolescents. Advanced drug delivery reviews. 2006 Apr 20;58(1):4-14.
  15. Gosden PE, Bedford KA, Dixon JJ, Speidel BD, Leaf AA, Macgowan AP. Pharmacokinetics of once-a-day netilmicin (4.5 mg/kg) in neonates. Journal of chemotherapy. 2001 Jan 1;13(3):270-6.
  16. Ramezani AM, Shayanfar A, Manzoori JL, Jouyban A. Solubility of some basic drugs in dioxane+ water mixtures at 298.2 K. Latin American Journal of Pharmacy. 2012;31(8):1176-81.
  17. Millard JW, Alvarez-Nunez FA, Yalkowsky SH. Solubilization by cosolvents: Establishing useful constants for the log–linear model. International Journal of Pharmaceutics. 2002 Oct 1;245(1-2):153-66.
  18. Vignesh M, Sivakumar M, Parkavi V, Selvakumar K, Joysa Ruby J. Stabilization of folic acid in liquid dosage form: formulation development, method validation and comparative analysis. Int J Pharm Chem Sci. 2012;1:332-8.
  19. Ali AA, Charoo NA, Abdallah DB. Pediatric drug development: formulation considerations. Drug development and industrial pharmacy. 2014 Oct 1;40(10):1283-99.
  20. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. New England Journal of Medicine. 2006 Apr 20;354(16):1698-705.
  21. Reddy LH, Ghosh B. Fast dissolving drug delivery systems: A review of the literature. Indian journal of pharmaceutical sciences. 2002;64(4):331-6.
  22. Aurora J, Pathak V. Oral disintegrating technologies: Oral disintegrating dosage forms: An overview. Drug Deliv Technol. 2005;5(3):50-4.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 14/12/2024
Accepted 07/01/2025
Published 13/02/2025
76